Ind-Swift Laboratories Limited (NSE:INDSWFTLAB)
India · Delayed Price · Currency is INR 164.19
+12.08 (7.94%)
Jun 1, 2026, 3:30 PM IST
Ind-Swift Laboratories Market Cap
Ind-Swift Laboratories has a market cap or net worth of 14.24 billion as of June 1, 2026. Its market cap has increased by 242.80% in one year.
Market Cap
14.24B
Enterprise Value
10.02B
Revenue
6.88B
Ranking
n/a
PE Ratio
33.92
Stock Price
164.19
Market Cap Chart
Since June 1, 1999, Ind-Swift Laboratories's market cap has increased from 111.51M to 14.24B, an increase of 12,667.17%. That is a compound annual growth rate of 19.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 13.19B | 83.34% |
| Dec 31, 2025 | 7.19B | 12.14% |
| Dec 31, 2024 | 6.42B | 4.85% |
| Dec 29, 2023 | 6.12B | 49.10% |
| Dec 30, 2022 | 4.10B | 2.21% |
| Dec 31, 2021 | 4.01B | 9.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Innova Captab | 48.66B |
| Orchid Pharma | 40.19B |
| RPG Life Sciences | 36.79B |
| Solara Active Pharma Sciences | 25.66B |
| Indoco Remedies | 19.35B |
| Sakar Healthcare | 17.72B |
| Windlas Biotech | 17.58B |
| Beta Drugs | 14.43B |